HOST CELL RECEPTOR

Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies

Elecsys® Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein. The spike protein is the target of many Covid-19 vaccines in development. This test may help identify recovering patients who could potentially be serum and plasma donors for developing treatments for Covid-19